Recently, my laboratory has developed a new class of immunotherapeutic agents termed Chemically Programmed Antibodies or CovX-bodies as prepared by Pfizer-CovX Inc. In this presentation, I will attempt to summarize some of our results concerning this promising new class of immunotherapeutic molecules. In the later part of my talk I will consider a new approach to vaccines based a chemical approach to vaccinology that has the potential to provide 'instant immunity'. Given time, new conjugation chemistries will be considered.

Chemically programmed antibodies and vaccines

243rd National Meeting (2012)

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.